RxDoctor Payments Data

William Crowley, DO

Family Medicine · Port Lavaca, TXNPI 1609870161

Payments from drug & device makers

$1,762in general payments, 2019–2025

Across 109 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$414
  • Amgen$272
  • Lilly USA, LLC$198
  • Pfizer$156
  • Merck$120
  • AstraZeneca$116
  • plus $486 from 13 others

What the payments were for

  • Food & beverage$1,75099%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,762 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$10,629
Medicare patients
25
Services billed
103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine26$92,790
EliquisApixaban65$78,135
OzempicSemaglutide70$66,867
JanuviaSitagliptin Phosphate55$61,604
RybelsusSemaglutide42$54,459
XareltoRivaroxaban38$38,647
JardianceEmpagliflozin18$23,042
FarxigaDapagliflozin Propanediol19$17,875
JanumetSitagliptin Phos/Metformin Hcl13$15,466
Trokendi XrTopiramate12$15,009
LinzessLinaclotide11$14,681
Breo ElliptaFluticasone/Vilanterol21$11,878
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,270
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$10,062
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$9,405

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$414$121,326112 claims
Teva Pharmaceuticals USA, Inc.Austedo$70$92,79026 claims
PfizerEliquis$156$78,13565 claims
MerckJanuvia, Janumet$120$77,07068 claims
Johnson & JohnsonXarelto$30$38,64738 claims
GSKBreo Ellipta, Trelegy Ellipta, Anoro Ellipta, Shingrix$58$34,51770 claims
AstraZenecaFarxiga, Breztri Aerosphere$116$29,14537 claims
Boehringer IngelheimJardiance$97$23,04218 claims
AbbVieLinzess$25$14,68111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Port Lavaca

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →